- Home
- RILY vs APLT Comparison
RILY vs APLT Comparison
Compare RILY & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILY
- APLT
- Stock Information
- Founded
- RILY 1973
- APLT 2016
- Country
- RILY United States
- APLT United States
- Employees
- RILY N/A
- APLT N/A
- Industry
- RILY Investment Managers
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- RILY Finance
- APLT Health Care
- Exchange
- RILY Nasdaq
- APLT Nasdaq
- Market Cap
- RILY 154.9M
- APLT 178.6M
- IPO Year
- RILY 2007
- APLT 2019
- Fundamental
- Price
- RILY $5.69
- APLT $1.28
- Analyst Decision
- RILY
- APLT Buy
- Analyst Count
- RILY 0
- APLT 5
- Target Price
- RILY N/A
- APLT $4.13
- AVG Volume (30 Days)
- RILY 629.5K
- APLT 5.8M
- Earning Date
- RILY 11-13-2025
- APLT 11-10-2025
- Dividend Yield
- RILY N/A
- APLT N/A
- EPS Growth
- RILY N/A
- APLT N/A
- EPS
- RILY N/A
- APLT N/A
- Revenue
- RILY $639,161,000.00
- APLT $121,000.00
- Revenue This Year
- RILY N/A
- APLT N/A
- Revenue Next Year
- RILY N/A
- APLT $5,935.35
- P/E Ratio
- RILY N/A
- APLT N/A
- Revenue Growth
- RILY N/A
- APLT N/A
- 52 Week Low
- RILY $2.67
- APLT $0.30
- 52 Week High
- RILY $7.90
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- RILY 49.16
- APLT 61.11
- Support Level
- RILY $4.98
- APLT $1.16
- Resistance Level
- RILY $5.77
- APLT $1.50
- Average True Range (ATR)
- RILY 0.36
- APLT 0.14
- MACD
- RILY 0.00
- APLT -0.01
- Stochastic Oscillator
- RILY 41.07
- APLT 63.31
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.